Резултати

еНаука >  Резултати >  Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Назив: Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes
Аутори: Xochelli, Aliki; Baliakas, Panagiotis; Kavakiotis, Ioannis; Agathangelidis, Andreas; Sutton, Lesley-Ann; Minga, Eva; Ntoufa, Stavroula; Tausch, Eugen; Yan, Xiao-Jie; Shanafelt, Tait;
Година: 2017
Публикација: Clinical Cancer Research
ISSN: 1078-0432 Clinical Cancer Research Претражи идентификатор
Издавач: Denville, NJ : The Association
Тип резултата: Научни чланак
Колација: vol. 23 br. 17 str. 5292-5301
DOI: 10.1158/1078-0432.ccr-16-3100
WoS-ID: 000409037300034
Scopus-ID: 2-s2.0-85029456308
PMID: 28536306
URI: https://enauka.gov.rs/handle/123456789/166765
https://imagine.imgge.bg.ac.rs/handle/123456789/1017
https://imagine.imgge.bg.ac.rs/handle/123456789/1611
URL: https://aacrjournals.org/clincancerres/article/23/17/5292/122592/Chronic-Lymphocytic-Leukemia-with-Mutated-IGHV4-34
Пројекат: H "AEGLE, An analytics framework for integrated and personalized healthcare services in Europe", by the EU
H project "MEDGENET, Medical Genomics and Epigenomics Network" by the EU [692298]
Swedish Cancer Society
Swedish Research Council
Uppsala University
Uppsala University Hospital
Lion's Cancer Research Foundation
Selander's Foundation, Uppsala
Associazione Italiana per la Ricerca sul Cancro, Milano, Italy [IG15189, 9965, 10007]
Ricerca Finalizzata [RF-2010-2318823]
Ministero della Salute, Roma, Italy [RF-2011-02349712]
MEYS CZ project NPUII - CEITEC [LQ1601]
Novo Nordisk Fonden [NNF16OC0019302] Funding Source: researchfish
The Danish Cancer Society [R130-A8217] Funding Source: researchfish
Извор метаподатака: Migracija
М-категорија: 
21aM21a - Рад у међ. часопису изузетних вредности

33
SCOPUSTM
18
PubMed CentralTM
20
OpenCitations
30
WEB OF SCIENCETM
Алт метрика
Dimensions
Unpaywall

Резултати на еНаука су заштићени ауторским правима и сва права су задржана, осим ако није другачије назначено.